H.R. 8440 · 117th Congress · House

Right to Try Clarification Act

Active· Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Introduced
Jul 20, 22
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Right to Try Clarification Act

This bill specifies that investigational drugs that are provided directly to individuals from manufacturers without the need for federal regulatory approval (i.e., via the Right to Try pathway) are exempt from restrictions that would otherwise apply under the Controlled Substances Act (e.g., restrictions on the use or possession of schedule I controlled substances).

Action Timeline

6
  1. NOV 01, 2022•Committee

    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

  2. JUL 20, 2022•IntroReferral

    Introduced in House

  3. JUL 20, 2022•IntroReferral

    Introduced in House

  4. JUL 20, 2022•IntroReferral

    Sponsor introductory remarks on measure. (CR E757)

  5. JUL 20, 2022•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. JUL 20, 2022•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

3

Crime and Federal Government Surveillance Subcommittee

hsju08

Referred: Nov 1, 2022

Active

Judiciary Committee

hsju00

Referred: Jul 20, 2022

Active

Energy and Commerce Committee

hsif00

Referred: Jul 20, 2022

Active